OPG/Osteoprotegerin Antibody (TR1BK1): sc-53976

OPG Antibody (TR1BK1) is a mouse monoclonal IgG2a antibody that detects osteoprotegerin (OPG) in human samples through immunoprecipitation (IP) and enzyme-linked immunosorbent assay (ELISA) applications. OPG is a crucial secreted glycoprotein that plays a significant role in bone metabolism by inhibiting osteoclastogenesis, which is the process of forming osteoclasts responsible for bone resorption. This inhibition is vital for maintaining bone density and volume, as excessive osteoclast activity can lead to conditions such as osteoporosis. OPG functions by disrupting the signaling between osteoblastic stromal cells and osteoclast progenitors, effectively preventing the differentiation of these progenitors into mature osteoclasts. Additionally, OPG interacts with TRAIL, a protein involved in apoptosis, and with osteoclast differentiation factor (ODF), also known as TRANCE/RANKL, which is essential for osteoclast formation. The regulation of OPG expression is influenced by various factors, including TNFα and TNFβ, which upregulate expression, while prostaglandin E2, a bone-resorbing agent, downregulates expression. Anti-OPG antibody (TR1BK1) is an invaluable tool for researchers studying bone metabolism and related disorders, providing insights into the mechanisms of osteoclast regulation and potential therapeutic targets.

The preferred OPG/Osteoprotegerin antibody is OPG/Osteoprotegerin Antibody (E-10): sc-390518.